An innovative approach to the way we
diagnose and monitor food allergies
Ambiguity persists in food allergy science5
Overreliance on panels to assess allergic disease continues to exist5
Up to 840k children are misdiagnosed with peanut allergy 1,2,4
Overdiagnosis increases psychological, behavioral, & financial costs6,7
As many as 60% of food allergy sufferers may be
misdiagnosed, leading to unnecessary food avoidance, increased patient anxiety, and annual costs of nearly $25 billion in the US alone. AllerGenis is working to change that.1-4
AllerGenis is creating a database of epitope signatures from real allergy patients
to bring more confidence to food allergy diagnosis and management.
We leverage our deep expertise in immunology and
bioinformatics to bring innovative solutions to the
diagnosis and management of food allergies.
At AllerGenis, we are dedicated to harnessing 21st century
technology, science and data to help improve the lives of
millions of food allergy patients and their families.